Sensible Biotechnologies

Raised $47M in a Series A round, announced 6 October 2026.

Round

Sensible Biotechnologies secured $47 million, including a Series A led by Oxford Science Enterprises and up to $20 million in non-dilutive funding, to advance its mRNA platform.

Amount: $47M
Stage: Series A
Announced: 6 October 2026
Lead: Oxford Science Enterprises
Checked: Amount and date matched across 2 press sources

Company

Develops naturally modified mRNA medicines using an AI-enabled platform

Sector: AI
Website: sensible.bio ↗

Sources and links

Sources: Sensible Biotechnologies Raises $47M in Funding - FinSMEs news.google.com
Sensible Biotechnologies Secures $47 Million to Advance Naturally Modified mRNA Platform and Unlock Next Gener biospace.com
Website: sensible.bio ↗

Just raised?

MediaBoost gets your round in front of the press, future hires and your next investors.

Announce your round with MediaBoost